- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Beauty Health Co(SKIN)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for SKIN
10/26/2026: SKIN (1-star) is currently NOT-A-BUY. Pass it for now.
The Beauty Health Company is a growth-oriented firm in the aesthetic industry, known primarily for its HydraFacial device and related high-margin consumables. The company benefits from a recurring revenue model and a strong brand presence within the professional skin health space. However, it faces risks, including intense competition from alternative aesthetic technologies, operational challenges, and sensitivity to discretionary spending. Investors should consider that while the company has potential for international expansion, its financial performance has been inconsistent. It is best suited for growth-oriented investors who can tolerate volatility and are monitoring the impact of recent sales restructuring and leadership stability.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers exposure to high-growth aesthetics but faces significant execution and profitability hurdles. |
| Momentum investor | Weak fit | The stock has experienced high volatility and is currently sensitive to a lack of clear, consistent upward price trends. |
| Value investor | Mixed fit | While valuations may appear lower than past peaks, the uncertainty regarding future earnings makes it a complex value proposition. |
| Dividend investor | Weak fit | The company does not pay dividends and focuses entirely on capital reinvestment. |
| Low-risk investor | Weak fit | High price volatility and operational challenges make this an unsuitable choice for risk-averse investors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock exhibits wide price swings common in emerging aesthetic companies. |
| Valuation risk | Medium | Valuation remains contingent on achieving forecasted growth and margin targets. |
| Competition risk (Aesthetic Technology) | High | Rapid innovation from competitors like InMode can erode market share. |
| Business quality | Medium | While the brand is strong, operational consistency has been a recent challenge. |
| Dividend income | Low / none | There is no income component for shareholders. |
| Execution risk | High | The company must successfully navigate organizational and sales restructuring. |
Price Behavior

Steep Decline
The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -64.92% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 70.88M USD | Price to earnings Ratio - | 1Y Target Price 15.67 |
Price to earnings Ratio - | 1Y Target Price 15.67 | ||
Volume (30-day avg) 28.8K shares | Beta 1.05 | 52 Weeks Range 9.89 - 34.80 | Updated Date 10/25/2026 |
52 Weeks Range 9.89 - 34.80 | Updated Date 10/25/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -4.6 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| HydraFacial Systems | Sale of proprietary aesthetic devices to medspas and dermatologists. | The upfront revenue from machine sales. |
| Consumables | Sale of proprietary tips and serums required for every treatment. | The recurring high-margin revenue stream. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 106.38 | Enterprise Value 380.33M | Price to Sales(TTM) 0.24 |
Enterprise Value 380.33M | Price to Sales(TTM) 0.24 | ||
Enterprise Value to Revenue 1.23 | Enterprise Value to EBITDA 18.37 | Shares Outstanding 6.51M | Shares Floating 2.55M |
Shares Outstanding 6.51M | Shares Floating 2.55M | ||
Percent Insiders 12.88 | Percent Institutions 77.06 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

